Literature DB >> 3917315

Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis.

R Jansson, A Karlsson, P A Dahlberg.   

Abstract

Ten hypothyroid patients with Hashimoto's thyroiditis were treated with methimazole 30 mg in addition to thyroxine 0.15 mg daily. Another 10 hypothyroid patients with Hashimoto's thyroiditis were given thyroxine 0.15 mg alone. After 22 weeks of treatment significant decreases in thyroid microsomal autoantibody titres were observed in both groups (p less than 0.01). There was no difference in the mean change in titre between the two groups. When the patients treated with methimazole were subsequently given thyroxine 0.15 mg alone for a further 22 weeks no additional change in titre was observed. The data suggest that thyroxine, by normalising serum thyroid stimulating hormone concentrations, may reduce the autoantigenic properties of the thyrocytes with a subsequent decrease in autoantibody titres.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917315      PMCID: PMC1415424          DOI: 10.1136/bmj.290.6461.11

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.

Authors:  G Fenzi; K Hashizume; C P Roudebush; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

2.  Are antithyroid drugs immunosuppressive?

Authors:  P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

3.  Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.

Authors:  C S Teng; R T Yeung
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

4.  Effects of antithyroid drugs on lymphocyte function in vitro.

Authors:  B Hallengren; A Forsgren; A Melander
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

5.  Inhibition of immunoglobulin-secreting cells by antithyroid drugs.

Authors:  I Weiss; T F Davies
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

6.  The accumulation of [35S]methimazole by human and rat lymphocytes.

Authors:  G S Shewring; J H Lazarus
Journal:  Acta Endocrinol (Copenh)       Date:  1983-01

7.  Carbimazole and the autoimmune response in Graves' disease.

Authors:  A M McGregor; M M Petersen; S M McLachlan; P Rooke; B R Smith; R Hall
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

8.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

9.  Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease.

Authors:  F A Karlsson; P A Dahlberg
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

10.  Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis.

Authors:  A M McGregor; H K Ibbertson; B R Smith; R Hall
Journal:  Br Med J       Date:  1980-10-11
View more
  10 in total

Review 1.  Thyroid disease during pregnancy.

Authors:  G N Burrow
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

2.  Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.

Authors:  L Chiovato; P Vitti; A Lombardi; G Lopez; F Santini; E Macchia; G F Fenzi; C Mammoli; S Battiato; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

3.  Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens.

Authors:  T R Brown; R S Sundick; A Dhar; D Sheth; N Bagchi
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.

Authors:  J H Romaldini; M C Werner; H F Rodrigues; V L Teixeira; R S Werner; C S Farah; N Bromberg
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

5.  The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes.

Authors:  M Bagnasco; D Venuti; G Ciprandi; G Pesce; F Paolieri; G W Canonica
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

6.  The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.

Authors:  N Bromberg; J H Romaldini; R S Werner; J A Sgarbi; M C Werner
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

7.  Differential immunosuppressive action of carbimazole and propylthiouracil.

Authors:  R Wilson; J H McKillop; C Pearson; A K Burnett; J A Thomson
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis.

Authors:  L Chiovato; C Marcocci; S Mariotti; A Mori; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

9.  Adding carbimazole to levothyroxine increases triiodothyronine and improves outcome in patients with primary hypothyroidism: a preliminary study from Egypt.

Authors:  Khaled Nagy Elfayoumy; Usama Bahgat Elgazzar; Mohamed Aboalabbas; Ahmed Salama Al-Adl
Journal:  Electron Physician       Date:  2017-02-25

10.  Variations in the Antithyroid Antibody Titre During Pregnancy and After Delivery.

Authors:  Chuyu Li; Na Zhang; Jing Zhou; Wingting Leung; Hans-Jürgen Gober; Zengshu Huang; Xinyao Pan; Lijia Chen; Liang Guan; Ling Wang
Journal:  Risk Manag Healthc Policy       Date:  2021-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.